OptimizeRx (NASDAQ:OPRX – Get Free Report) and Corpay (NYSE:CPAY – Get Free Report) are both computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation.
Institutional & Insider Ownership
76.5% of OptimizeRx shares are held by institutional investors. Comparatively, 98.8% of Corpay shares are held by institutional investors. 6.1% of OptimizeRx shares are held by company insiders. Comparatively, 6.1% of Corpay shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Risk & Volatility
OptimizeRx has a beta of 1.38, meaning that its stock price is 38% more volatile than the S&P 500. Comparatively, Corpay has a beta of 1.28, meaning that its stock price is 28% more volatile than the S&P 500.
Valuation and Earnings
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
OptimizeRx | $71.52 million | 1.49 | -$17.57 million | ($1.33) | -4.35 |
Corpay | $3.76 billion | 7.04 | $981.89 million | $14.02 | 27.07 |
Corpay has higher revenue and earnings than OptimizeRx. OptimizeRx is trading at a lower price-to-earnings ratio than Corpay, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares OptimizeRx and Corpay’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
OptimizeRx | -27.41% | -4.92% | -3.41% |
Corpay | 26.14% | 39.44% | 7.54% |
Analyst Recommendations
This is a summary of recent ratings and recommmendations for OptimizeRx and Corpay, as reported by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
OptimizeRx | 0 | 3 | 6 | 0 | 2.67 |
Corpay | 0 | 3 | 11 | 1 | 2.87 |
OptimizeRx currently has a consensus target price of $9.06, suggesting a potential upside of 56.52%. Corpay has a consensus target price of $381.43, suggesting a potential upside of 0.49%. Given OptimizeRx’s higher possible upside, analysts plainly believe OptimizeRx is more favorable than Corpay.
Summary
Corpay beats OptimizeRx on 12 of the 14 factors compared between the two stocks.
About OptimizeRx
OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.
About Corpay
Corpay, Inc. operates as a payments company that helps businesses and consumers manage vehicle-related expenses, lodging expenses, and corporate payments in the United States, Brazil, the United Kingdom, and internationally. The company offers vehicle payment solutions, which include fuel, tolls, parking, fleet maintenance, and long-haul transportation services, as well as prepaid food and transportation vouchers and cards. It also provides corporate payment solutions consisting of accounts payable automation; virtual cards, cross-border solutions; and purchasing and travel and entertainment card products, as well as lodging payments solutions for employees who travel overnight for work purposes; traveling crews and stranded passengers from airlines and cruise lines; and insurance policyholders displaced from their homes due to damage or catastrophe. In addition, the company offers gifts and payroll cards. It serves business, merchant, consumer, and payment network customers. The company was formerly known as FLEETCOR Technologies, Inc. and changed its name to Corpay, Inc. in March 2024. Corpay, Inc. was founded in 1986 and is headquartered in Atlanta, Georgia.
Receive News & Ratings for OptimizeRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptimizeRx and related companies with MarketBeat.com's FREE daily email newsletter.